Cyclerion Therapeutics Inc
CYCN
Get informed when a big investor buys or sells
+ FollowMarket Cap$18.21M
Close$
$0.58
85.5% downside
Current Fair Value
85.5% downsideOvervalued by 85.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $18.21 Million |
|---|---|
| Enterprise Value | $16.82 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.09 |
| Beta | 1.75 |
| Outstanding Shares | 4,251,000 |
Return
| Return on Equity | -131.85% |
|---|---|
| Return on Assets | -96.78% |
| Return on Invested Capital | -133.24% |
Valuation & Multiples
| P/E Ratio | -2.26 |
|---|---|
| PEG | -0.51 |
| Price to Sales | - |
| Price to Book Ratio | 4.0 |
| Enterprise Value to Revenue | 8.85 |
| Enterprise Value to EBIT | -2.48 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$-7.10
Average shareholder expectationRevenue Estimate
$1.50 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-6.00
Average shareholder expectationRevenue Estimate
$900,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.85%▼ 5.34% |
|---|---|
| Total Invested | $249,026▼ 33.81% |
| Investors Holding | 17▼ 2.00% |
ESG Score
No data